SALUBRISBIO Trademark

Trademark Overview


On Friday, May 9, 2025, a trademark application was filed for SALUBRISBIO with the United States Patent and Trademark Office. The USPTO has given the SALUBRISBIO trademark a serial number of 99177965. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 28, 2025. This trademark is owned by SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.. The SALUBRISBIO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-diabetic pharmaceuticals; Injectable dermal filler; Enzymes for medical purposes; Insulin; Vaccines for human use; Diagnostic preparations for medical purposes; Dietetic foods adapted for medical use; Pharmaceutical preparations, namely, elixirs for the treatment of cardiovascular and cerebrovascular system, hematologic disorders, dermatological diseases, ophthalmic diseases, and gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and hypersensitivity diseases; Biological preparations for the treatment of cardiovascular and cerebrovascular system, hematologic disorders, dermatological diseases, ophthalmic diseases, and gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and hypersensitivity diseases; Bio...
salubrisbio

General Information


Serial Number99177965
Word MarkSALUBRISBIO
Filing DateFriday, May 9, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 28, 2025

Trademark Statements


Goods and ServicesAnti-diabetic pharmaceuticals; Injectable dermal filler; Enzymes for medical purposes; Insulin; Vaccines for human use; Diagnostic preparations for medical purposes; Dietetic foods adapted for medical use; Pharmaceutical preparations, namely, elixirs for the treatment of cardiovascular and cerebrovascular system, hematologic disorders, dermatological diseases, ophthalmic diseases, and gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and hypersensitivity diseases; Biological preparations for the treatment of cardiovascular and cerebrovascular system, hematologic disorders, dermatological diseases, ophthalmic diseases, and gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and hypersensitivity diseases; Biologics in the nature of cells for medical use
Pseudo MarkSALUBRIS BIO

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 9, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressShenzhen, Guangdong 518000
CN

Party NameSHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShenzhen, Guangdong 518000
CN

Trademark Events


Event DateEvent Description
Friday, May 9, 2025NEW APPLICATION ENTERED
Friday, May 9, 2025APPLICATION FILING RECEIPT MAILED
Friday, September 19, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 24, 2025ASSIGNED TO EXAMINER
Monday, September 29, 2025EXAMINERS AMENDMENT -WRITTEN
Monday, September 29, 2025EXAMINERS AMENDMENT E-MAILED
Monday, September 29, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 29, 2025EXAMINER'S AMENDMENT ENTERED
Monday, September 29, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 28, 2025PUBLISHED FOR OPPOSITION
Tuesday, October 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED